Introduction

In this audio webcast, Dr. Michael Klinkman, Associate Professor in the Departments of Medicine and Psychiatry at the University of Michigan, and Director of the Primary Care Programs at the University of Michigan Depression Center will provide a comprehensive overview of the psychopharmacology for depression, including treatment options, alternative therapies, patient selection criteria, monitoring treatment response and principles of care.

Intended Audience

This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with major depressive disorder.

Educational Objectives

After completing this activity, participants should be better able to:

• Describe commonly-used antidepressant medications including dosing ranges, costs, and side effects.
• Select an appropriate pharmacotherapy and monitor the effectiveness of treatment.
• Apply the evidence-based approaches (STAR*D Trial) to the treatment of depression.
• Describe considerations for referral to specialty care.

Information on CME credit

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Medical Association designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nonphysicians may receive a certificate of participation for completing this activity.

Instructions for CME credit

This online enduring material is presented as an audio webcast with attendant slide presentation. To receive credit, please view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.

The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.

Advisory Board/Content Reviewers

Wayne Katon, MD
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA

Kurt Kroenke, MD
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN

John Williams, MD
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC

Editorial Board

R. Mark Evans, PhD
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Kristi Eidsvoog, PhD
Content Manager
MedEd Architects, LLC
Chicago, IL

Patti Fitzgerald
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Faculty

Michael S. Klinkman, MD
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI

Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.

These materials have been peer-reviewed by the members of the Program Advisory Board and the AMA Editorial Board to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.

Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline

Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology

Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth

Dr. Williams: Nothing relevant to disclose

Dr. Evans: Nothing relevant to disclose

Dr. Eidsvoog: Nothing relevant to disclose

Ms. Fitzgerald: Nothing relevant to disclose

Acknowledgement of Support

These CME offerings are supported through an independent education grant from Eli Lilly and Company, and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.

Term of approval

December, 2007 through December, 2008